Sassicaia-Capital-Advisers

AI_NATIVE detailed information: This accession holds the following tickers:[
  "BABA",
  null,
  "META",
  null,
  null,
  null,
  "MA",
  "MSFT",
  "AAPL",
  "SPY",
  "NVDA",
  "GS",
  "PLTR",
  null,
  "MSTR",
  "LYRA",
  "GRRR",
  "TSM",
  "AMZN",
  "WMT",
  null,
  "CVNA",
  "CELH",
  "CORT",
  "QQQ",
  "TSLA",
  "NFLX"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 27
Total Value: 27610217
Accession Number: 0001420506-25-001217
Form Type: 13F-HR
CIK: sassicaia-capital-advisers
Manager Name: Sassicaia-Capital-Advisers

Data Enrichment

78% identified

21 identified6 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

27 positions • $27,610.217K total value

27 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Page 2 of 2

Sort by:

G6077Y301

Shares:9.6K

Value:$232.8K

Mastercard Inc

MA|57636Q104

Shares:400

Value:$219.2K

GOLDMAN SACHS GROUP INC

GS|38141G104

Shares:400

Value:$218.5K

063679534

Shares:600

Value:$216.0K

25460G195

Shares:5.0K

Value:$207.3K

450958301

Shares:14.0K

Value:$31.4K

Lyra Therapeutics, Inc.

LYRA|55234L105

Shares:10.0K

Value:$1.3K

Instrument	Shares		Other Manager	Value
(cusipG6077Y301)✕	9.6K	QoQ NEW(+9.6K) YoY NEW(+9.6K)	All Managers (Combined)	$232.8K	QoQ NEW(+$232.8K) YoY NEW(+$232.8K)
Mastercard Inc(MAcusip57636Q104)	400	QoQ NEW(+400) YoY -20.00% (-100)	All Managers (Combined)	$219.2K	QoQ NEW(+$219.2K) YoY -8.94% (-$21.5K)
GOLDMAN SACHS GROUP INC(GScusip38141G104)	400	QoQ NEW(+400) YoY NEW(+400)	All Managers (Combined)	$218.5K	QoQ NEW(+$218.5K) YoY NEW(+$218.5K)
(cusip063679534)✕	600	QoQ NEW(+600) YoY NEW(+600)	All Managers (Combined)	$216.0K	QoQ NEW(+$216.0K) YoY NEW(+$216.0K)
(cusip25460G195)✕	5.0K	QoQ NEW(+5.0K) YoY NEW(+5.0K)	All Managers (Combined)	$207.3K	QoQ NEW(+$207.3K) YoY NEW(+$207.3K)
(cusip450958301)✕	14.0K	QoQ NEW(+14.0K) YoY NEW(+14.0K)	All Managers (Combined)	$31.4K	QoQ NEW(+$31.4K) YoY NEW(+$31.4K)
Lyra Therapeutics, Inc.(LYRAcusip55234L105)	10.0K	QoQ NEW(+10.0K) YoY NEW(+10.0K)	All Managers (Combined)	$1.3K	QoQ NEW(+$1.3K) YoY NEW(+$1.3K)